Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy

Human Molecular Genetics

Volumn 24, Issue 8, 2015, Pages 2147-2162

  Giordano, Christian ^a   Mojumdar, Kamalika ^a   Liang, Feng ^a   Lemaire, Christian ^a   Li, Tong ^a   Richardson, John ^b   Divangahi, Maziar ^a   Qureshi, Salman ^a,c   Petrof, Basil J ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; TOLL LIKE RECEPTOR 4; GLYCYRRHIZIC ACID; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GENE EXPRESSION; IMMUNOPATHOLOGY; IN VITRO STUDY; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; MUSCULAR DYSTROPHY, DUCHENNE; SKELETAL MUSCLE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

MUS;

ANIMALS; FEMALE; GLYCYRRHIZIC ACID; HUMANS; IMMUNITY, INNATE; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; TOLL-LIKE RECEPTOR 4;

EID: 84926430427     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu735     Document Type: Article

References (67)

1. Petrof, B.J. (2002) Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex. Am. J. Phys. Med. Rehabil., 81, S162-S174.
2. Manzur, A.Y., Kuntzer, T., Pike, M. and Swan, A. (2008) Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane. Database. Syst. Rev., doi: 10.1002/14651858. CD003725.pub3.
3. Stedman, H.H., Sweeney, H.L., Shrager, J.B., Maguire, H.C., Panettieri, R.A., Petrof, B., Narusawa, M., Leferovich, J.M., Sladky, J.T. and Kelly, A.M. (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature, 352, 536-539.
4. Morrison, J., Lu, Q.L., Pastoret, C., Partridge, T. and Bou-Gharios, G. (2000) T-cell-dependent fibrosis in the mdx dystrophic mouse. Lab Invest., 80, 881-891.
5. Wehling-Henricks, M., Sokolow, S., Lee, J.J., Myung, K.H., Villalta, S.A. and Tidball, J.G. (2008) Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. Hum. Mol. Genet., 17, 2280-2292.
6. Wehling, M., Spencer, M.J. and Tidball, J.G. (2001) A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J. Cell Biol., 155, 123-131.
7. Acharyya, S., Villalta, S.A., Bakkar, N., Bupha-Intr, T., Janssen, P.M., Carathers, M., Li, Z.W., Beg, A.A., Ghosh, S., Sahenk, Z. et al. (2007) Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J. Clin. Invest., 117, 889-901.
8. Radley, H.G., Davies, M.J. and Grounds, M.D. (2008) Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment. Neuromuscul. Disord., 18, 227-238.
9. Chen, Y.W., Nagaraju, K., Bakay, M., McIntyre, O., Rawat, R., Shi, R. and Hoffman, E.P. (2005) Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology, 65, 826-834.
10. Kawai, T. and Akira, S. (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol., 11, 373-384.
11. Bianchi, M.E. (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol., 81, 1-5.
12. Chen, G.Y. and Nunez, G. (2010) Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol., 10, 826-837.
13. Klune, J.R., Dhupar, R., Cardinal, J., Billiar, T.R. and Tsung, A. (2008) HMGB1: endogenous danger signaling. Mol. Med., 14, 476-484.
14. Scaffidi, P., Misteli, T. and Bianchi, M.E. (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 418, 191-195.
15. Xu, H., Su, Z., Wu, J., Yang, M., Penninger, J.M., Martin, C.M., Kvietys, P.R. and Rui, T. (2010) The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway. J. Immunol., 184, 1492-1498.
16. Gardella, S., Andrei, C., Ferrera, D., Lotti, L.V., Torrisi, M.R., Bianchi, M.E. and Rubartelli, A. (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep., 3, 995-1001.
17. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J.M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science, 285, 248-251.
18. Andrassy, M., Volz, H.C., Igwe, J.C., Funke, B., Eichberger, S.N., Kaya, Z., Buss, S., Autschbach, F., Pleger, S.T., Lukic, I.K. et al. (2008) High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation, 117, 3216-3226.
19. Caso, J.R., Pradillo, J.M., Hurtado, O., Lorenzo, P., Moro, M.A. and Lizasoain, I. (2007) Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation, 115, 1599-1608.
20. Okuma, Y., Liu, K., Wake, H., Zhang, J., Maruo, T., Date, I., Yoshino, T., Ohtsuka, A., Otani, N., Tomura, S. et al. (2012) Anti-high mobility group box-1 antibody therapy for traumatic brain injury. Ann. Neurol., 72, 373-384.
21. Oyama, J., Blais, C., Jr, Liu, X., Pu, M., Kobzik, L., Kelly, R.A. and Bourcier, T. (2004) Reduced myocardial ischemia-reperfusion injury in Toll-like receptor 4-deficient mice. Circulation, 109, 784-789.
22. Karpati, G., Carpenter, S. and Prescott, S. (1988) Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve, 11, 795-803.
23. Villalta, S.A., Nguyen, H.X., Deng, B., Gotoh, T. and Tidball, J.G. (2009) Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum. Mol. Genet., 18, 482-496.
24. Sica, A. and Mantovani, A. (2012) Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest., 122, 787-795.
25. Mollica, L., De Marchis, F., Spitaleri, A., Dallacosta, C., Pennacchini, D., Zamai, M., Agresti, A., Trisciuoglio, L., Musco, G. and Bianchi, M.E. (2007) Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem. Biol., 14, 431-441.
26. Okimasu, E., Moromizato, Y., Watanabe, S., Sasaki, J., Shiraishi, N., Morimoto, Y.M., Miyahara, M. and Utsumi, K. (1983) Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug. Acta Med. Okayama, 37, 385-391.
27. Boyd, J.H., Divangahi, M., Yahiaoui, L., Gvozdic, D., Qureshi, S. and Petrof, B.J. (2006) Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin. Infect. Immun., 74, 6829-6838.
28. Lu, H., Huang, D., Ransohoff, R.M. and Zhou, L. (2011) Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J., 25, 3344-3355.
29. Shi, C., Jia, T., Mendez-Ferrer, S., Hohl, T.M., Serbina, N.V., Lipuma, L., Leiner, I., Li, M.O., Frenette, P.S. and Pamer, E.G. (2011) Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating Toll-like receptor ligands. Immunity, 34, 590-601.
30. Boivin, A., Pineau, I., Barrette, B., Filali, M., Vallieres, N., Rivest, S. and Lacroix, S. (2007) Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J. Neurosci., 27, 12565-12576.
31. Tsung, A., Klune, J.R., Zhang, X., Jeyabalan, G., Cao, Z., Peng, X., Stolz, D.B., Geller, D.A., Rosengart, M.R. and Billiar, T.R. (2007) HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J. Exp. Med., 204, 2913-2923.
32. Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M.M., Garg, H.G., Quinn, D.A. et al. (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med., 11, 1173-1179.
33. Doz, E., Noulin, N., Boichot, E., Guenon, I., Fick, L., Le, B.M., Lagente, V., Ryffel, B., Schnyder, B., Quesniaux, V.F. et al. (2008) Cigarette smoke-induced pulmonary inflammation is TLR4/ MyD88 and IL-1R1/MyD88 signaling dependent. J. Immunol., 180, 1169-1178.
34. Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H. and Flier, J.S. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest., 116, 3015-3025.
35. Stewart, C.R., Stuart, L.M., Wilkinson, K., van Gils, J.M., Deng, J., Halle, A., Rayner, K.J., Boyer, L., Zhong, R., Frazier, W.A. et al. (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol., 11, 155-161.
36. Serrano, A.L. and Munoz-Canoves, P. (2010) Regulation and dysregulation of fibrosis in skeletal muscle. Exp. Cell Res., 316, 3050-3058.
37. Pesce, J.T., Ramalingam, T.R., Mentink-Kane, M.M., Wilson, M. S., El Kasmi, K.C., Smith, A.M., Thompson, R.W., Cheever, A. W., Murray, P.J. and Wynn, T.A. (2009) Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS. Pathog., 5, e1000371.
38. Wilson, M.S., Elnekave, E., Mentink-Kane, M.M., Hodges, M.G., Pesce, J.T., Ramalingam, T.R., Thompson, R.W., Kamanaka, M., Flavell, R.A., Keane-Myers, A. et al. (2007) IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J. Clin. Invest., 117, 2941-2951.
39. Tidball, J.G. and Villalta, S.A. (2010) Regulatory interactions between muscle and the immune system during muscle regeneration. Am. J. Physiol. Regul. Integr. Comp. Physiol., 298, R1173-R1187.
40. Villalta, S.A., Deng, B., Rinaldi, C., Wehling-Henricks, M. and Tidball, J.G. (2011) IFN-gamma promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation. J. Immunol., 187, 5419-5428.
41. Villalta, S.A., Rinaldi, C., Deng, B., Liu, G., Fedor, B. and Tidball, J.G. (2011) Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum. Mol. Genet., 20, 790-805.
42. Vetrone, S.A., Montecino-Rodriguez, E., Kudryashova, E., Kramerova, I., Hoffman, E.P., Liu, S.D., Miceli, M.C. and Spencer, M.J. (2009) Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. J. Clin. Invest, 119, 1583-1594.
43. Taylor, K.R., Yamasaki, K., Radek, K.A., Di, N.A., Goodarzi, H., Golenbock, D., Beutler, B. and Gallo, R.L. (2007) Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J. Biol. Chem., 282, 18265-18275.
44. Okamura, Y., Watari, M., Jerud, E.S., Young, D.W., Ishizaka, S. T., Rose, J., Chow, J.C. and Strauss, J.F. III (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem., 276, 10229-10233.
45. Schaefer, L., Babelova, A., Kiss, E., Hausser, H.J., Baliova, M., Krzyzankova, M., Marsche, G., Young, M.F., Mihalik, D., Gotte, M. et al. (2005) The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest, 115, 2223-2233.
46. Smiley, S.T., King, J.A. and Hancock, W.W. (2001) Fibrinogen stimulates macrophage chemokine secretion through Tolllike receptor 4. J. Immunol., 167, 2887-2894.
47. Barrera, V., Skorokhod, O.A., Baci, D., Gremo, G., Arese, P. and Schwarzer, E. (2011) Host fibrinogen stably bound to hemozoin rapidly activates monocytes via TLR-4 and CD11b/CD18-integrin: a new paradigm of hemozoin action. Blood, 117, 5674-5682.
48. Grundtman, C., Bruton, J., Yamada, T., Ostberg, T., Pisetsky, D. S., Harris, H.E., Andersson, U., Lundberg, I.E. and Westerblad, H. (2010) Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J., 24, 570-578.
49. Yang, H., Hreggvidsdottir, H.S., Palmblad, K., Wang, H., Ochani, M., Li, J., Lu, B., Chavan, S., Rosas-Ballina, M., Al-Abed, Y. et al. (2010) A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl. Acad. Sci. USA, 107, 11942-11947.
50. Lv, B., Wang, H., Tang, Y., Fan, Z., Xiao, X. and Chen, F. (2009) High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-kappaB and Egr-1. Thromb. Haemost., 102, 352-359.
51. Mabuchi, A., Wake, K., Marlini, M., Watanabe, H. and Wheatley, A.M. (2009) Protection by glycyrrhizin against warm ischemia-reperfusion-induced cellular injury and derangement of the microcirculatory blood flow in the rat liver. Microcirculation, 16, 364-376.
52. Schiraldi, M., Raucci, A., Munoz, L.M., Livoti, E., Celona, B., Venereau, E., Apuzzo, T., De, M.F., Pedotti, M., Bachi, A. et al. (2012) HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J. Exp. Med., 209, 551-563.
53. Tang, D., Billiar, T.R. and Lotze, M.T. (2012) A Janus tale of two active high mobility group box 1 (HMGB1) redox states. Mol. Med., 18, 1360-1362.
54. Vidal, B., Serrano, A.L., Tjwa, M., Suelves, M., Ardite, E., De Mori, R., Baeza-Raja, B., Martínez de Lagrán, M., Lafuste, P., Ruiz-Bonilla, V. et al. (2008) Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes Dev., 22, 1747-1752.
55. Charan, R.A., Niizawa, G., Nakai, H. and Clemens, P.R. (2013) Adeno-associated virus serotype 8 (AAV8) delivery of recombinant A20 to skeletal muscle reduces pathological activation of nuclear factor (NF)-kappaB in muscle of mdx mice. Mol. Med., 18, 1527-1535.
56. Amenta, A.R., Yilmaz, A., Bogdanovich, S., McKechnie, B.A., Abedi, M., Khurana, T.S. and Fallon, J.R. (2011) Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice. Proc. Natl. Acad. Sci. USA, 108, 762-767.
57. Henriques-Pons, A., Yu, Q., Rayavarapu, S., Cohen, T.V., Ampong, B., Cha, H.J., Jahnke, V., VanderMeulen, J., Wang, D., Wayne, J. et al. (2014) Role of Toll like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle. Hum. Mol. Genet., 23, 2604-2617.
58. Uaesoontrachoon, K., Cha, H.-J., Ampong, B., Sali, A., Vandermeulen, J., Wei, B., Creeden, B., Huynh, T., Quinn, J., Tatem, K. et al. (2013) The effects of MyD88 deficiency on disease phenotype in dysferlin-deficient A/J mice: role of endogenous TLR ligands. J. Pathol., 231, 199-209.
59. Tu, J.H., He, Y.J., Chen, Y., Fan, L., Zhang, W., Tan, Z.R., Huang, Y.F., Guo, D., Hu, D.L., Wang, D. et al. (2010) Effect of glycyrrhizin on the activity of CYP3A enzyme in humans. Eur. J. Clin. Pharmacol., 66, 805-810.
60. Manns, M.P., Wedemeyer, H., Singer, A., Khomutjanskaja, N., Dienes, H.P., Roskams, T., Goldin, R., Hehnke, U. and Inoue, H. (2012) Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks. J. Viral Hepat., 19, 537-546.
61. 5cv) mice manifest more severe muscle dysfunction and diaphragm force deficits than do mdx Mice. Am. J. Pathol., 179, 2464-2474.
62. Briguet, A., Courdier-Fruh, I., Foster, M., Meier, T. and Magyar, J.P. (2004) Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul. Disord., 14, 675-682.
63. Schneider, C.A., Rasband, W.S. and Eliceiri, K.W. (2012) NIH Image to ImageJ: 25 years of image analysis. Nat. Methods, 9, 671-675.
64. Straub, V., Rafael, J.A., Chamberlain, J.S. and Campbell, K.P. (1997) Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol., 139, 375-385.
65. Divangahi, M., Demoule, A., Danialou, G., Yahiaoui, L., Bao, W., Xing, Z. and Petrof, B.J. (2007) Impact of IL-10 on diaphragmatic cytokine expression and contractility during Pseudomonas Infection. Am. J. Respir. Cell Mol. Biol., 36, 504-512.
66. Stout, R.D., Jiang, C., Matta, B., Tietzel, I., Watkins, S.K. and Suttles, J. (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol., 175, 342-349.
67. Agarwal, R., Wang, Z.Y. and Mukhtar, H. (1991) Inhibition of mouse skin tumor-initiating activity of DMBA by chronic oral feeding of glycyrrhizin in drinking water. Nutr. Cancer, 15, 187-193.